Trial Number
566-25
Condition
Prostate Cancer
Participant Age Range
18 years and older
Participant Gender
Male
Enrolling Participants
Yes
Overview
“SpaceIT Hydrogel System for Perirectal Spacing in Subjects with Low to Intermediate Risk Prostate Cancer Undergoing External Beam Radiotherapy (EBRT): A Multicenter, Randomized, Controlled Clinical Study (HYDROSPACE)”
To evaluate the safety and effectiveness of the SpaceIT™ Hydrogel System in patients undergoing External Beam Radiotherapy (EBRT) for the treatment of prostate cancer.